高级检索
当前位置: 首页 > 详情页

Myeloid leukemia factor 1: A "double-edged sword" in health and disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China. [2]Hematology Research Center of Yunnan Province, Kunming, China. [3]Department of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, China.
出处:
ISSN:

关键词: myeloid leukemia factor 1 nucleo-cytoplasmic shuttling protein cell cycle regulation immune function cell development and differentiation malignancy development

摘要:
The occurrence and development of malignancies are closely related to abnormal cell cycle regulation. Myeloid leukemia factor 1 (MLF1) is a small nucleocytoplasmic shuttling protein associated with cell cycle exit, apoptosis, and certain immune functions. Therefore, it is pertinent to explore the role of MLF1 in health and diseases. Studies to date have suggested that MLF1 could act as a double-edged sword, regulating biochemical activities directly or indirectly. In hematopoietic cells, it serves as a protective factor for the development of lineages, and in malignancies, it serves as an oncogenesis factor. The diversity of its functions depends on the binding partners, including tumor inhibitors, scaffolding molecules, mitochondrial membrane proteins, and transcription factors. Emerging evidence indicates that MLF1 influences immune responses as well. This paper reviews the structure, biological function, and research progress on MLF1 in health and diseases to provide new insights for future research.Copyright © 2023 Li, Yang, Wu, Li and Shi.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China. [2]Hematology Research Center of Yunnan Province, Kunming, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China. [2]Hematology Research Center of Yunnan Province, Kunming, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52538 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)